CVS HEALTH Corp(CVS)— Stock Profile, AI Score & Financials

Healthcare · NYSE · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated 2026-06-30.

CVS HEALTH Corp (CVS) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores CVS at 59.4/100 on a 32-signal composite quality model, placing it at rank #927 of 2,961 stocks — the top half of the AI-ranked universe. CVS scores in the top quartile across revenue scale (99.8), earnings quality (90.0). Areas of concern include free cash flow (35.0) and profitability (37.6), which score below median versus the broader universe. Based on the latest XBRL financial filings (Q2 2026), CVS HEALTH Corp reports quarterly revenue of $106.1B, net income of $3.0B, an operating margin of 4.4%. Top institutional holders of CVS by reported 13-F value include BlackRock, VANGUARD CAPITAL MANAGEMENT, Capital World Investors, based on the most recent SEC filings. CVS trades on the NYSE exchange and files with the SEC under CIK 64803. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate CVS daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for CVS HEALTH Corp directly from SEC EDGAR.